Clinical Trials Browser

Phase 2/3 × Vomiting × Olanzapine × Clear all

NCT03631004 2022-01-13

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Phase 2/3 Completed

Nausea, Vomiting, Postoperative Nausea and Vomiting

NCT03137121 2021-08-17

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

Phase 2/3 Completed

30 enrolled 9 charts

Nausea, Vomiting